...
首页> 外文期刊>Materials science & engineering, C. Materials for Biogical applications >Design and characterization of dexamethasone-loaded poly (glycerol sebacate)-poly caprolactone/gelatin scaffold by coaxial electro spinning for soft tissue engineering
【24h】

Design and characterization of dexamethasone-loaded poly (glycerol sebacate)-poly caprolactone/gelatin scaffold by coaxial electro spinning for soft tissue engineering

机译:用同轴电纺织软组织工程同轴电旋转地塞米松加载聚(甘油癸二酸酯) - 己内酮/明胶支架的设计与表征

获取原文
获取原文并翻译 | 示例
           

摘要

The aim of this research was to fabricate dexamethasone (Dex)-loaded poly (glycerol sebacate) (PGS)-poly (caprolactone) (PCL)/gelatin (Gt) (PGS-PCL/Gt-Dex) fibrous scaffolds in the form of core/shell structure which have potential application in soft tissues. In this regard, after synthesize and characterizations of PGS, PGS-PCL and gelatin fibrous scaffolds were separately developed in order to optimize the electrospinning parameters. In the next step, coaxial electrospun fibrous scaffold of PGS-PCL/Gt fibrous scaffold with PGS-PCL as core and Gt as shell was developed and its mechanical, physical and chemical properties were characterized. Moreover, degradability, hydrophilicity and biocompatibility of PGS-PCL/Gt fibrous scaffold were evaluated. In addition, Dex was encapsulated in PGS-PCL/Gt fibrous scaffold and drug release was assessed for tissue engineering application. Results demonstrated the formation of coaxial fibrous scaffold with average porosity of 79% and average fiber size of 294 nm. Moreover, PGS-PCL/Gt fibrous scaffold revealed lower elastic modulus, ultimate tensile and ultimate elongation than those of PGS-PCL scaffold and more close to mechanical properties of natural tissue. Furthermore, lower contact angle of PGS-PCL/Gt than that of PGS-PCL demonstrated improved surface hydrophilicity of scaffold. DEX release was sustained over a period time of 30 days from the scaffolds via three steps consisting of an initial burst release, secondary linear phase release pattern with slower rate over 20 days followed by an apparent zero-order release phase. MTT observations demonstrated that there was no evidence of toxicity in the samples with and without Dex. Our findings indicated that core/shell PGS-PCL/Gt-Dex fibrous could be used as a carrier for the sustained release of drugs relevant for tissue engineering which makes it appropriate for soft tissue engineering. (C) 2017 Elsevier B.V. All rights reserved.
机译:该研究的目的是制造地塞米松(DEX) - 加载的聚(甘油癸二酸盐)(PGS) - 磷胶(己内酯)/明胶(PCL)/明胶(PGS-PCL / GT-DEX)纤维支架中的形式在软组织中具有潜在应用的核心/壳结构。在这方面,在PGS的合成和表征后,分别开发PGS-PCL和明胶纤维支架以优化静电纺丝参数。在下一步骤中,开发了PGS-PCL / GT纤维支架的同轴电纺纤维支架,作为壳作为壳,其机械,物理和化学性质。此外,评价PGS-PCL / GT纤维支架的可降解性,亲水性和生物相容性。此外,DEX被包封在PGS-PCL / GT纤维支架中,并评估药物释放,用于组织工程应用。结果表明,形成同轴纤维支架,平均孔隙率为79%,平均纤维尺寸为294nm。此外,PGS-PCL / GT纤维支架显示出低于PGS-PCL支架的较低弹性模量,最终拉伸和最终伸长率,并且更接近于自然组织的机械性能。此外,PGS-PCL / GT的降低角度比PGS-PCL-PCL的接触角表明了支架的改善的表面亲水性。通过由初始突发释放组成的三个步骤,在支架上由支架30天的时间段持续30天,次级线性相位释放图案在20天超过20天后,随后是表观零阶释放阶段的三个步骤。 MTT观察表明,没有患有和没有德克斯的样品中没有毒性的证据。我们的研究结果表明,核/壳PGS-PCL / GT-DEX纤维可用作持续释放用于组织工程的药物的载体,这使其适合软组织工程。 (c)2017 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号